REQUEST A DEMO
Total
USD $0.00
Search more companies

Worldwide Clinical Trials Slovakia S.R.O. (Slovakia)

Main Activities: Management Consulting Services | Administrative Management and General Management Consulting Services
Full name: Worldwide Clinical Trials Slovakia S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Worldwide Clinical Trials Slovakia S.R.O. is a company based in Slovakia, with its head office in Bratislava. It operates in the Management Consulting Services industry. The company was established on July 04, 2009. The company’s latest financial report indicates a net sales revenue increase of 22.43% in 2025. There was a total growth of 38.24% in Worldwide Clinical Trials Slovakia S.R.O.’s total assets over the same period. Worldwide Clinical Trials Slovakia S.R.O.’s net profit margin increased by 0.92% in 2025.

Headquarters
Cintorinska, 7
Bratislava; Bratislavsky; Postal Code: 81108

Contact Details: Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.
Financial Auditors:
Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.
Incorporation Date:
July 04, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Worldwide Clinical Trials Slovakia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
22.43%
Total Operating Revenue
22.43%
Operating Profit
62.62%
EBITDA
62.62%
Net Profit/Loss for the Period
49.63%
Total Assets
38.24%
Total Equity
21.48%
Operating Profit Margin
1.99%
Net Profit Margin
0.92%
Return on Equity (ROE)
3.33%
Debt / Equity
-0.01%
Quick Ratio
-0.8%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?